Viral Shuttle Vector for Sulfolobus Gene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Recombinant protein expression in non-native organisms, such as Escherichia coli, often results in inactive enzymes due to lack of appropriate post-translational modifications and incorrect folding, and the development of broad recombinant DNA technologies for archaea has been slow due to their diverse biology and environments, making efficient cloning and expression in extremophiles like Sulfolobus challenging.

Innovation Solution

A novel recombinant nucleic acid capable of stably integrating into the chromosome of Sulfolobus species, utilizing a minimal inducible promoter and multiple cloning sites, allows for the expression and secretion of thermophilic enzymes that are stable at high temperatures and acidic conditions, enabling rapid and efficient production of acid/heat-stable enzymes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If recombinant protein expression is performed in non-native organisms like Escherichia coli, then production speed is improved, but enzyme activity and proper folding are compromised due to lack of appropriate post-translational modifications and binding partners

Engineering Contradiction:
Improveproduction speedVSAvoidenzyme activity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent uses a viral shuttle vector system as an intermediary to transfer genetic material between organisms. The vector contains viral elements (origin of replication, packaging signals, integrase) that enable efficient cloning in E. coli and subsequent integration into Sulfolobus chromosome, bridging the gap between rapid bacterial cloning and proper archaeal protein expression

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The expression system is divided into modular components: viral shuttle vector for cloning, integrase for chromosomal integration, selectable markers for selection, and inducible promoters for controlled expression. This segmentation allows optimization of each component for its specific function while working together as a complete system

Inventive Principle:
Principle #1Segmentation

2Adaptability or versatility

If viral shuttle vectors with large sizes (~20kb) are used for Sulfolobus, then complete gene expression capabilities are achieved, but cloning efficiency and speed are reduced

Engineering Contradiction:
Improvegene expression capabilitiesVSAvoidcloning efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent extracts only the essential viral elements needed for Sulfolobus gene transfer (origin of replication, packaging signals, integrase gene) and places them in a minimized vector backbone. Non-essential viral sequences are removed, creating a compact vector that maintains functionality while improving cloning efficiency

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The shuttle vector is designed to function in multiple organisms: it replicates in E. coli for cloning, packages into viral particles for Sulfolobus infection, and integrates into the archaeal chromosome. This multi-functionality is achieved through carefully selected universal elements that work across species boundaries

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If broad recombinant DNA technologies for archaea are developed, then application range is improved, but technical complexity increases due to highly diverse biology and environments

Engineering Contradiction:
Improveapplication rangeVSAvoidtechnical complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent creates a universal shuttle vector system that works across different Sulfolobus species and can be adapted for various expression needs. Standardized elements (multiple cloning sites, selectable markers, promoters) allow the same basic vector to be used for different genes and applications without redesigning the entire system

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system allows flexible adjustment of expression parameters through selectable markers (different antibiotics/resistances), inducible promoters (different induction conditions), and multiple cloning sites. These parameter changes enable adaptation to different experimental needs while maintaining the same core vector structure

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP2922957B1Nucleic acids useful for integrating into and gene expression in hyperthermophilic acidophilic archaea
Publication Date: 2023.01.04 RGT UNIV OF CALIFORNIA
  • EP2922957B1 patent drawingFigure 1a~1b
  • EP2922957B1 patent drawingFigure 2A~2D
  • EP2922957B1 patent drawingFigure 3A~3B

AI summary

The present invention provides for a novel recombinant or isolated nucleic acid useful for integrating or being maintained in an Archaea or acidophilic hyperthermophilic eubacteria. The nucleic acid encodes a nucleotide sequence that is capable of stably integrating into the chromosome of a host cell, or being maintained as an extrachromosomal element in a host cell, that is an Archea, and a nucleotide sequence of interest. The present invention also provides for an Archaea host cell comprising the nucleic acid stably integrated into the chromosome or maintained episomally in the host cell, and a method of expressing the nucleotide sequence of interest in the host cell and/or directing glycosylation, multimerization, and/or membrane association or integration.